• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于 14C-加速质谱生物学/生物医学/环境应用的石墨靶的质量。

Quality of graphite target for biological/biomedical/environmental applications of 14C-accelerator mass spectrometry.

机构信息

Department of Nutrition, University of California Davis, One Shields Avenue, Davis, California, 95616, USA.

出版信息

Anal Chem. 2010 Mar 15;82(6):2243-52. doi: 10.1021/ac9020769.

DOI:10.1021/ac9020769
PMID:20163100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2837469/
Abstract

Catalytic graphitization for (14)C-accelerator mass spectrometry ((14)C-AMS) produced various forms of elemental carbon. Our high-throughput Zn reduction method (C/Fe = 1:5, 500 degrees C, 3 h) produced the AMS target of graphite-coated iron powder (GCIP), a mix of nongraphitic carbon and Fe(3)C. Crystallinity of the AMS targets of GCIP (nongraphitic carbon) was increased to turbostratic carbon by raising the C/Fe ratio from 1:5 to 1:1 and the graphitization temperature from 500 to 585 degrees C. The AMS target of GCIP containing turbostratic carbon had a large isotopic fractionation and a low AMS ion current. The AMS target of GCIP containing turbostratic carbon also yielded less accurate/precise (14)C-AMS measurements because of the lower graphitization yield and lower thermal conductivity that were caused by the higher C/Fe ratio of 1:1. On the other hand, the AMS target of GCIP containing nongraphitic carbon had higher graphitization yield and better thermal conductivity over the AMS target of GCIP containing turbostratic carbon due to optimal surface area provided by the iron powder. Finally, graphitization yield and thermal conductivity were stronger determinants (over graphite crystallinity) for accurate/precise/high-throughput biological, biomedical, and environmental (14)C-AMS applications such as absorption, distribution, metabolism, elimination (ADME), and physiologically based pharmacokinetics (PBPK) of nutrients, drugs, phytochemicals, and environmental chemicals.

摘要

用于(14)C-加速质谱((14)C-AMS)的催化石墨化产生了各种形式的元素碳。我们的高通量 Zn 还原方法(C/Fe = 1:5、500°C、3 h)产生了石墨包覆铁粉(GCIP)的 AMS 靶,这是一种无定形碳和 Fe(3)C 的混合物。通过将 C/Fe 比从 1:5 提高到 1:1 和将石墨化温度从 500°C 提高到 585°C,GCIP(无定形碳)的 AMS 靶的结晶度增加到乱层石墨碳。GCIP 含有乱层石墨碳的 AMS 靶具有较大的同位素分馏和较低的 AMS 离子电流。GCIP 含有乱层石墨碳的 AMS 靶也由于较高的 C/Fe 比为 1:1 而导致较低的石墨化产率和较低的热导率,从而导致更不准确/不准确的(14)C-AMS 测量。另一方面,由于铁粉提供的最佳表面积,GCIP 含有无定形碳的 AMS 靶的石墨化产率和热导率均高于 GCIP 含有乱层石墨碳的 AMS 靶。最后,石墨化产率和热导率是准确/准确/高通量生物、生物医学和环境(14)C-AMS 应用的更重要决定因素(超过石墨结晶度),例如吸收、分布、代谢、消除(ADME)和基于生理学的药代动力学(PBPK)营养物质、药物、植物化学物质和环境化学物质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/890e/2837469/d739af5cf140/ac-2009-020769_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/890e/2837469/b11d558bdbe7/ac-2009-020769_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/890e/2837469/737123dbd695/ac-2009-020769_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/890e/2837469/7b89e17e0d51/ac-2009-020769_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/890e/2837469/f07e610d70a6/ac-2009-020769_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/890e/2837469/cf10a1af8ecb/ac-2009-020769_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/890e/2837469/d739af5cf140/ac-2009-020769_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/890e/2837469/b11d558bdbe7/ac-2009-020769_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/890e/2837469/737123dbd695/ac-2009-020769_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/890e/2837469/7b89e17e0d51/ac-2009-020769_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/890e/2837469/f07e610d70a6/ac-2009-020769_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/890e/2837469/cf10a1af8ecb/ac-2009-020769_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/890e/2837469/d739af5cf140/ac-2009-020769_0004.jpg

相似文献

1
Quality of graphite target for biological/biomedical/environmental applications of 14C-accelerator mass spectrometry.用于 14C-加速质谱生物学/生物医学/环境应用的石墨靶的质量。
Anal Chem. 2010 Mar 15;82(6):2243-52. doi: 10.1021/ac9020769.
2
Biological/biomedical accelerator mass spectrometry targets. 2. Physical, morphological, and structural characteristics.生物/生物医学加速器质谱分析目标。2. 物理、形态和结构特征。
Anal Chem. 2008 Oct 15;80(20):7661-9. doi: 10.1021/ac801228t. Epub 2008 Sep 12.
3
Biological/biomedical accelerator mass spectrometry targets. 1. optimizing the CO2 reduction step using zinc dust.生物/生物医学加速器质谱分析目标。1. 使用锌粉优化二氧化碳还原步骤。
Anal Chem. 2008 Oct 15;80(20):7651-60. doi: 10.1021/ac801226g. Epub 2008 Sep 12.
4
Biological and biomedical (14)C-accelerator mass spectrometry and graphitization of carbonaceous samples.生物和生物医学 (14)C-加速器质谱法和碳质样品的石墨化。
Analyst. 2013 Jun 21;138(12):3347-55. doi: 10.1039/c3an00077j. Epub 2013 Apr 29.
5
Accelerator mass spectrometry targets of submilligram carbonaceous samples using the high-throughput Zn reduction method.采用高通量锌还原法对亚毫克级含碳样品进行加速器质谱分析。
Anal Chem. 2009 Jul 15;81(14):5949-54. doi: 10.1021/ac900406r.
6
Recent advances in biomedical applications of accelerator mass spectrometry.加速器质谱技术在生物医学应用中的最新进展。
J Biomed Sci. 2009 Jun 17;16(1):54. doi: 10.1186/1423-0127-16-54.
7
Double Trap Interface: A novel gas interface for high throughput analysis of biomedical samples by AMS.双阱接口:一种用于通过 AMS 对生物医学样品进行高通量分析的新型气体接口。
Drug Metab Pharmacokinet. 2021 Aug;39:100400. doi: 10.1016/j.dmpk.2021.100400. Epub 2021 May 7.
8
Accelerator MS: its role as a frontline bioanalytical technique.加速器质谱:其作为一线生物分析技术的作用。
Bioanalysis. 2011 Dec;3(24):2817-23. doi: 10.4155/bio.11.285.
9
Comparison of a 250 kV single-stage accelerator mass spectrometer with a 5 MV tandem accelerator mass spectrometer--fitness for purpose in bioanalysis.250 kV单级加速器质谱仪与5 MV串列加速器质谱仪的比较——生物分析中的适用性
Rapid Commun Mass Spectrom. 2008 Dec;22(24):4035-42. doi: 10.1002/rcm.3829.
10
Attomole detection of 3H in biological samples using accelerator mass spectrometry: application in low-dose, dual-isotope tracer studies in conjunction with 14C accelerator mass spectrometry.使用加速器质谱法对生物样品中的3H进行阿托摩尔检测:在与14C加速器质谱法结合的低剂量双同位素示踪研究中的应用。
Chem Res Toxicol. 1998 Oct;11(10):1217-22. doi: 10.1021/tx9801458.

本文引用的文献

1
Accelerator mass spectrometry targets of submilligram carbonaceous samples using the high-throughput Zn reduction method.采用高通量锌还原法对亚毫克级含碳样品进行加速器质谱分析。
Anal Chem. 2009 Jul 15;81(14):5949-54. doi: 10.1021/ac900406r.
2
Biological/biomedical accelerator mass spectrometry targets. 2. Physical, morphological, and structural characteristics.生物/生物医学加速器质谱分析目标。2. 物理、形态和结构特征。
Anal Chem. 2008 Oct 15;80(20):7661-9. doi: 10.1021/ac801228t. Epub 2008 Sep 12.
3
Biological/biomedical accelerator mass spectrometry targets. 1. optimizing the CO2 reduction step using zinc dust.
生物/生物医学加速器质谱分析目标。1. 使用锌粉优化二氧化碳还原步骤。
Anal Chem. 2008 Oct 15;80(20):7651-60. doi: 10.1021/ac801226g. Epub 2008 Sep 12.
4
Accelerator mass spectrometry.加速器质谱分析法
Mass Spectrom Rev. 2008 Sep-Oct;27(5):398-427. doi: 10.1002/mas.20172.
5
Subattomole sensitivity in biological accelerator mass spectrometry.生物加速器质谱中的亚阿托摩尔灵敏度。
Anal Chem. 2008 May 15;80(10):3515-21. doi: 10.1021/ac800174j. Epub 2008 Apr 19.
6
Studying disorder in graphite-based systems by Raman spectroscopy.通过拉曼光谱研究石墨基体系中的无序现象。
Phys Chem Chem Phys. 2007 Mar 21;9(11):1276-91. doi: 10.1039/b613962k. Epub 2007 Jan 11.
7
Quantitating isotopic molecular labels with accelerator mass spectrometry.用加速器质谱法定量同位素分子标记物。
Methods Enzymol. 2005;402:402-22. doi: 10.1016/S0076-6879(05)02013-6.
8
A high-throughput method for the conversion of CO2 obtained from biochemical samples to graphite in septa-sealed vials for quantification of 14C via accelerator mass spectrometry.一种高通量方法,用于将生化样品中获得的二氧化碳在隔垫密封小瓶中转化为石墨,以便通过加速器质谱法对14C进行定量分析。
Anal Chem. 2003 May 1;75(9):2192-6. doi: 10.1021/ac026334j.
9
A method for characterizing carbon nanotubes.一种表征碳纳米管的方法。
J Electron Microsc (Tokyo). 2001;50(4):321-4. doi: 10.1093/jmicro/50.4.321.
10
Accelerator mass spectrometry.加速器质谱分析法
Anal Chem. 1995 Jun 1;67(11):353A-359A. doi: 10.1021/ac00107a001.